Share price was pumped from 10 to 49 cents on very little revenue generating details from the Ellume deal.
It turned out that revenue is negligible on MC projections for Anteo.
This is already proven from past quarterlies, so I do wonder why shareholders ponder
about the relevance of this contract.
ASX does not let company ride the same speculative wave twice on moderate to low revenue expections, is my guess.
Company needs to sell its own test in Europe, and quite a few mil of it to justify current MC. This is overdue.
Hopefully some domestic sales are added to it, all in all, shareholders have no idea what revenue numbers will be once sales start.
all IMO
AnteoTech renews AnteoBind contract with Ellume, page-21
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $54.77M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.2¢ | 2.0¢ | $12.70K | 583.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1191253 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 520012 | 3 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |